Shares in San Diego, USA-based Acadia Pharmaceuticals fell around a fifth ahead of the opening bell on Tuesday, following poor results from the ADVANCE-2 trial. 12 March 2024
A final report for KarXT (xanomeline tartrate/trospium chloride) has been published by influential pricing watchdog The Institute for Clinical and Economic Revi 12 March 2024
Privately-held German firm Boehringer Ingelheim and Japan’s Sosei Group Corporation have entered into a global collaboration and exclusive option-to-license agr 11 March 2024
US drugmaker Eli Lilly had expected to hear whether its amyloid plaque-targeting therapy donanemab had been approved in the USA to treat early symptomatic Alzhe 8 March 2024
San Diego-based Kenai Therapeutics, a biotech leveraging induced pluripotent stem cell (iPSC) tech to discover and develop a platform of allogeneic neuron repla 29 February 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.